Heyu Biological Technology Corporation reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was USD 0.010121 million compared to USD 0.015135 million a year ago. Net loss was USD 0.148377 million compared to USD 0.049515 million a year ago.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.2226 USD | -.--% | -.--% | -36.18% |
Apr. 01 | Hongchang International Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Apr. 01 | Hongchang International Co., Ltd Announces Board Changes | CI |
1st Jan change | Capi. | |
---|---|---|
-36.18% | 115M | |
+26.29% | 661B | |
+26.74% | 566B | |
-6.38% | 352B | |
+19.24% | 332B | |
+3.85% | 283B | |
+13.43% | 231B | |
+4.71% | 200B | |
-9.53% | 195B | |
-3.97% | 145B |
- Stock Market
- Equities
- HCIL Stock
- News Hongchang International Co., Ltd
- Heyu Biological Technology Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023